Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. While COPD is a mainly chronic disease, a substantial number of patients suffer …

As the third leading cause of death in the United States in 2014, chronic obstructive
pulmonary disease (COPD) presents a significant challenge to the health care provider. 1 …

Progressive lung function decline is a hallmark of chronic obstructive pulmonary disease
(COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression …

Background As many as 89% of people with Parkinson's disease (PD) develop speech
disorders. Objectives This randomized controlled trial evaluated two speech treatments for …

Abstract In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease
(GVHD) Consensus Response Criteria Working Group recommended several measures to …

Background: Patients with chronic obstructive pulmonary disease (COPD) often present with
severe acute exacerbations requiring hospital treatment. However, little is known about the …

Neutrophil activation by inflammatory stimuli and the release of extracellular chromatin
structures (neutrophil extracellular traps–NETs) have been implicated in inflammatory …

Chronic obstructive pulmonary disease (COPD) is a progressive condition of chronic
bronchitis, small airway obstruction, and emphysema that represents a leading cause of …

Background Smoking cessation is the most important treatment for smokers with chronic
obstructive pulmonary disease (COPD), but little is known about the effectiveness of different …

Rationale: Understanding normal lung development and aging in health and disease, both
in men and in women, is essential to interpreting any therapeutic intervention. Objectives …